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Abstract
According to the International Headache Society, idiopathic stabbing headache (ISH), an
indomethacin-responsive headache syndrome, is a paroxysmal disorder of short duration
manifested as head pain occurring as a single stab or a series of stabs involving the area supplied in
the distribution of the first division of the trigeminal nerve. Stabs last for approximately a few
seconds, occurring and recurring from once to multiple times per day in an irregular frequency,
with no underlying attributable disorder.
Previously indomethacin was the principle treatment option for ISH, despite therapeutic failure in
up to 35% of cases, until reports showed gabapentin, melatonin and selective cyclo-oxygenase-2
(COX-2) inhibitors were also possibly effective. In this report we present the full case report of an
88 year old lady with a history of untreated ISH where etoricoxib, a selective COX-2 inhibitor, was
used to effectively treat her ISH.
Introduction
Idiopathic stabbing headache (ISH) was first described in
1964 by Lansche [1] and over the years in has been known
by many synonyms, e.g. "ophthalmodynia periodica",
"ice-pick headache syndrome" and "jabs and jolts".
Recently it has been included as a separate entity in the
classification of the International Headache Society (IHS)
– "other primary headaches". [2]
ISH is a paroxysmal disorder manifested as transient pain-
ful stabs, predominantly or exclusively felt in the distribu-
tion of the ophthalmic division of the trigeminal nerve
[3]. It has a life-time prevalence in the region of 2% [4]
with onset primarily in middle or late stages of life (mean
age of 47 years) [5] and a female preponderance. [5]
The first line treatment of ISH has traditionally been
indomethacin, which has a therapeutic failure rate in up
to 35% of cases. [6] Previously novel treatments have
been reported in the medical literature, including nifed-
ipine [7], gabapentin [3], melatonin [8] and selective
COX-2 inhibitors. [9] Here we present another case where
the use of a selective COX-2 inhibitor was used to effec-
tively treat ISH.
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Case presentation
An 88 year old lady presented to the Accident and Emer-
gency department of our hospital complaining of head-
aches, dehydration, vomiting and general malaise for two
days. Her past medical history included hypertension,
Alzheimer's disease (diagnosed in 2003), right hip frac-
ture and right wrist fracture (1996). Medications on
admission included, donepezil hydrochloride 5 mg PO
BD, aspirin 75 mg PO OD and trandolapril 2 mg PO OD.
She had no known drug allergies. On examination she
had reduced skin turgor; nil else of note. Investigations
showed normal haematology, biochemistry and haema-
tinics. Previous brain imaging was unremarkable.
On diligent history taking it was discovered the she had a
history of idiopathic stabbing headache, which at the time
of admission was not being treated. The nature of the his-
tory was described as follows: stabbing pains on the
crown and right temporal areas, which often occurred
multiple times during the day without warning and last
for only a few seconds on each occasion. There were days
where these headaches were not experienced. She
described if the ambient temperature is elevated exacerba-
tions may also be exacerbated, especially at night, while
touching the named sites of the scalp often induces
attacks of pain, making hair-care a major difficulty. There
were no accompanying symptoms prior to at the time of
this admission. Despite a history of Alzheimer's disease
her headache history was very clear and coherent.
Due to the potential side-effect profile of indomethacin in
an 88 year old patient, it was decided to commence oral
etoricoxib, 60 mg given once daily with food. The patient
reported a major improvement in symptoms within days.
Her headache had completely resolved within a week and
our records to date show no return of her symptoms.
Discussion
Indomethacin-responsive headache syndromes represent
a unique group of primary headache disorders. They can
be divided into several distinct categories: a select group of
trigeminal-autonomic cephalgies, valsalva-induced head-
aches, and ISH. The paroxysmal and continuous hemicra-
nias invariably respond in an absolute manner to
indomethacin, whereas valsalva-induced headaches and
ISH may respond in an equally dramatic, but somewhat
less consistent fashion. [5] The response to indomethacin
is not a criterion for the diagnosis of valsalva-induced
headaches and ISH, unlike in paroxysmal hemicrania
where the IHS has made it an obligatory criterion. [2]
The definitive diagnosis of ISH is based upon clear details
or description obtained from the history, with neuroimag-
ing being unhelpful. The IHS criteria for diagnosis are that
the pain is: (A) confined to the head, exclusively or pre-
dominantly felt in the distribution of the first division of
the trigeminal nerve (orbital, temporal and parietal
regions), (B) stabbing in nature and lasting fractions of a
second, (C) recurring at irregular intervals (hours to days)
and (D) occurring in the absence of organic disease. [2] In
the region of 57% report daily episodes, 14% weekly, 23%
monthly and 6% yearly episodes. [6] Episodes may last
from fractions of a second (69% of cases) to rarely more
than 10 seconds. [6] According to the Vaga study the
majority (94.6%) last up to 3 seconds. [9] Clinically Idio-
pathic stabbing headache patients suffer brief, sharp, or
stabbing pains that occur either as a single episode or in
brief repeated volleys of pain. The pain usually lasts from
5 to 10 seconds, is of moderate severity, and may recur up
to 50 times daily. [6] The syndrome may also have other
manifestations such as gastrointestinal discomfort and
vertigo [3], while the mechanisms in the pathologies of
the syndrome remain unclear.
The current medical literature highlights that the onset of
attacks of ISH is generally spontaneous but sometimes can
be related to cerebrovascular disease, cranial trauma and
herpes zoster. [3,9] In most sufferers the pain is unpro-
voked, however precipitating triggers have been recorded
in the past and these include: rapid alterations in posture,
physical exertion, bright light and head motion during
migraine attacks. [10] This is the first reported case,
known to us, where direct physical contact and a change
in ambient temperature may act as triggers.
Previous studies have found that there can be a close rela-
tion between the occurrence of ISH and other headaches
in adults. There is up to a 63% association with migraine
[9], but also links are seen with tension-type headache
(27.3%) [9] and hemicrania continua. [3] In such cases
the pain is usually localized and occurs preferentially on
the side most frequently affected by migraine attacks. [3]
Indomethacin has traditionally been the first line treat-
ment for ISH, despite its unfavourable side-effects profile,
and a therapeutic failure rate in at least 35% of cases [6]
and partial response in 30%. [6] It is postulated that the
physiology of Indomethacin possibly reduces cerebral
and meningeal blood flow and antagonists effects in the
nitric oxide pathways [3], and thus produces its therapeu-
tic effect in ISH. It is recommended to start with
indomethacin 12.5 mg two – three times per day, increas-
ing the dose on alternate days until a response is apparent.
[6] The majority of patients with ISH respond to a dose of
indomethacin of 25 to 50 mg three times daily. [6]
Recently there have been reports of other medications,
with more favourable side-effect profiles, being used for
ISH, namely nifedipine [7], gabapentin [3], melatonin [8]
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In this case, we did not carry out an indomethacin treat-
ment trial due to the risks of using such a medication in
the elderly [9], while etoricoxib is equipotent and better
tolerated. [9]
It is difficult to be 100% certain that the clinical response
seen in this case is exclusively due to etoricoxib as ISH has
a natural course of spontaneous fluctuations with only
14% suffering from persistent symptoms. [6] Therefore in
accordance with other COX-2 inhibitors being used effec-
tively in ISH it may be worthwhile looking at the possibil-
ity of clinical trails in alternative treatment options. In the
interim, we conclude that a selective COX-2 inhibitor,
namely etoricoxib, is possibly another treatment option
for ISH and may be a safer therapeutic option than
indomethacin due to the lower side-effect profile. The
long term safety of using a COX-2 inhibitor remains under
investigation. [11]
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